annual ROE:
-54.00%-11.90%(-28.27%)Summary
- As of today (August 20, 2025), NTLA annual return on equity is -54.00%, with the most recent change of -11.90% (-28.27%) on December 31, 2024.
- During the last 3 years, NTLA annual ROE has fallen by -19.82% (-57.99%).
- NTLA annual ROE is now -136.63% below its all-time high of -22.82%, reached on December 31, 2016.
Performance
NTLA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-55.83%+1.07%(+1.88%)Summary
- As of today (August 20, 2025), NTLA quarterly return on equity is -55.83%, with the most recent change of +1.07% (+1.88%) on June 30, 2025.
- Over the past year, NTLA quarterly ROE has dropped by -6.90% (-14.10%).
- NTLA quarterly ROE is now -195.48% below its all-time high of 58.47%, reached on December 31, 2015.
Performance
NTLA quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NTLA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | -14.1% |
| 3 y3 years | -58.0% | -24.8% |
| 5 y5 years | -48.6% | -36.7% |
NTLA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.0% | at low | -31.9% | +1.9% |
| 5 y | 5-year | -60.3% | at low | -54.9% | +1.9% |
| alltime | all time | -136.6% | +57.2% | -195.5% | +37.5% |
NTLA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -55.83%(-1.9%) |
| Mar 2025 | - | -56.90%(+7.3%) |
| Dec 2024 | -54.00%(+28.3%) | -53.05%(+2.7%) |
| Sep 2024 | - | -51.64%(+5.5%) |
| Jun 2024 | - | -48.93%(+9.2%) |
| Mar 2024 | - | -44.79%(+4.6%) |
| Dec 2023 | -42.10%(+1.0%) | -42.82%(-0.1%) |
| Sep 2023 | - | -42.87%(-1.0%) |
| Jun 2023 | - | -43.29%(+2.3%) |
| Mar 2023 | - | -42.32%(-11.9%) |
| Dec 2022 | -41.67%(+21.9%) | -48.04%(+4.5%) |
| Sep 2022 | - | -45.98%(+2.8%) |
| Jun 2022 | - | -44.73%(+0.5%) |
| Mar 2022 | - | -44.49%(+23.4%) |
| Dec 2021 | -34.18%(+1.5%) | -36.05%(-5.3%) |
| Sep 2021 | - | -38.08%(-7.4%) |
| Jun 2021 | - | -41.14%(+10.8%) |
| Mar 2021 | - | -37.12%(-4.6%) |
| Dec 2020 | -33.69% | -38.89%(-4.7%) |
| Sep 2020 | - | -40.80%(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -40.83%(-0.4%) |
| Mar 2020 | - | -40.99%(+12.4%) |
| Dec 2019 | -36.34%(+23.2%) | -36.47%(+9.7%) |
| Sep 2019 | - | -33.25%(+1.3%) |
| Jun 2019 | - | -32.82%(+5.5%) |
| Mar 2019 | - | -31.12%(+3.3%) |
| Dec 2018 | -29.50%(+11.5%) | -30.12%(-12.2%) |
| Sep 2018 | - | -34.32%(+2.6%) |
| Jun 2018 | - | -33.46%(+1.7%) |
| Mar 2018 | - | -32.89%(+4.6%) |
| Dec 2017 | -26.46%(+16.0%) | -31.45%(+15.2%) |
| Sep 2017 | - | -27.31%(+22.6%) |
| Jun 2017 | - | -22.27%(+8.2%) |
| Mar 2017 | - | -20.58%(+15.9%) |
| Dec 2016 | -22.82%(-31.0%) | -17.75%(-33.7%) |
| Sep 2016 | - | -26.76%(-28.5%) |
| Jun 2016 | - | -37.41%(-58.1%) |
| Mar 2016 | - | -89.35%(-252.8%) |
| Dec 2015 | -33.09%(-73.8%) | 58.47% |
| Dec 2014 | -126.08% | - |
FAQ
- What is Intellia Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual ROE year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly ROE year-on-year change?
What is Intellia Therapeutics, Inc. annual return on equity?
The current annual ROE of NTLA is -54.00%
What is the all time high annual ROE for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual return on equity is -22.82%
What is Intellia Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, NTLA annual return on equity has changed by -11.90% (-28.27%)
What is Intellia Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of NTLA is -55.83%
What is the all time high quarterly ROE for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly return on equity is 58.47%
What is Intellia Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, NTLA quarterly return on equity has changed by -6.90% (-14.10%)